Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 5/20 | 0.78 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.78 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | LDHA | P00338 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL7981840 | 1.00 | CA4 (0.78) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL7620105 | 1.00 | CA4 (0.78) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL28387560 | 1.00 | CA4 (0.78) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL169342 | 1.00 | — | — | |
| Oxalic Acid SCHEMBL2722478 | 1.00 | CA4 (0.78) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL23794556 | 0.94 | CA4 (0.70) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL25340214 | 0.94 | CA4 (0.70) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL21047559 | 0.94 | CA4 (0.70) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL25291950 | 0.94 | CA4 (0.70) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL20495937 | 0.94 | CA4 (0.70) | CA4FAHD1MEN1LDHABLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 223 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4507722-A1 | NANOEMULSION UNIVERSAL INFLUENZA VACCINE | Bluewillow Biologics, Inc. (US) | 2025-02-19 | — | — | EP | claimed |
| US-20240398854-A1 | OPHTHALMIC FORMULATIONS AND METHODS FOR THEIR USE | Panaseea, LLC (US) | 2024-12-05 | — | — | US | claimed |
| US-20240058434-A1 | NANOEMULSION UNIVERSAL INFLUENZA VACCINE | BLUEWILLOW BIOLOGICS, INC. (US) | 2024-02-22 | — | — | US | claimed |
| WO-2023200764-A1 | NANOEMULSION UNIVERSAL INFLUENZA VACCINE | BLUEWILLOW BIOLOGICS, INC. (US) | 2023-10-19 | — | — | WO | claimed |
| US-20190209471-A1 | BUFFERED COMPOSITIONS AND METHODS FOR THEIR USE IN SURFACE TREATMENTS | Panaseea, LLC (US) | 2019-07-11 | — | — | US | claimed |
| CN-109930011-A | A kind of vanadium aluminum separation method containing vanadium solution | 武汉科技大学 | 2019-06-25 | — | — | CN | claimed |
| CN-109825717-A | A method of recycling magnesium, iron and aluminium step by step from containing vanadium solution | 武汉科技大学 | 2019-05-31 | — | — | CN | claimed |
| CN-105226264-B | A kind of sodium-ion battery richness sodium positive electrode and preparation method thereof and sodium-ion battery | 北京理工大学 | 2018-12-14 | — | — | CN | claimed |
| CN-106082722-B | A kind of cementitious material and its application | 昆明理工大学 | 2018-08-31 | — | — | CN | claimed |
| CN-106007430-B | A kind of copper ashes base iron system oxalate chemical bonding material and application thereof | 昆明理工大学 | 2018-06-19 | — | — | CN | claimed |
| WO-2010036938-A2 | NANOEMULSION THERAPEUTIC COMPOSITIONS AND METHODS OF USING THE SAME | NANOBIO CORPORATION (US) | 2010-04-01 | — | — | WO | claimed |
| US-20100075914-A1 | METHODS FOR TREATING HERPES VIRUS INFECTIONS | NANOBIO CORPORATION | 2010-03-25 | — | — | US | claimed |
| US-20090304799-A1 | NANOEMULSION INFLUENZA VACCINE | NANOBIO CORPORATION | 2009-12-10 | — | — | US | claimed |
| US-20090269380-A1 | METHODS OF TREATING FUNGAL, YEAST AND MOLD INFECTIONS | NANOBIO CORPORATION | 2009-10-29 | — | — | US | claimed |
| US-20090269394-A1 | METHODS AND COMPOSITIONS FOR TREATING ONCHOMYCOSIS | NANOBIO CORPORATION | 2009-10-29 | — | — | US | claimed |
| WO-2009132342-A1 | NANOEMULSIONS FOR TREATING FUNGAL, YEAST AND MOLD INFECTIONS | NANOBIO CORPORATION (US) | 2009-10-29 | — | — | WO | claimed |
| WO-2009131995-A1 | NANOEMULSION INFLUENZA VACCINE | NANOBIO CORPORATION (US) | 2009-10-29 | — | — | WO | claimed |
| WO-2009132343-A1 | NANOEMULSIONS FOR TREATING ONCHOMYCOSIS | NANOBIO CORPORATION (US) | 2009-10-29 | — | — | WO | claimed |
| WO-2009129470-A2 | METHODS FOR TREATING HERPES VIRUS INFECTIONS | NANOBIO CORPORATION (US) | 2009-10-22 | — | — | WO | claimed |
| CN-1064986-C | Composition for cleaning and etching electronic display and substrate | LEE KI WON (KR) | 2001-04-25 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090269394-A1 | METHODS AND COMPOSITIONS FOR TREATING ONCHOMYCOSIS | DPM1, ERG28, POLR1C | CA4 1545/4885FAHD1 409/4885MEN1 969/4885 |
| US-20100075914-A1 | METHODS FOR TREATING HERPES VIRUS INFECTIONS | STING1, IFNG, NGF | CA4 287/4885FAHD1 3104/4885MEN1 4237/4885 |
| US-20090269380-A1 | METHODS OF TREATING FUNGAL, YEAST AND MOLD INFECTIONS | DPM1, ERG28, CYP51A1 | CA4 526/4885FAHD1 1134/4885MEN1 624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.